Deciphering Adverse Outcome Pathway Network Linked to Bisphenol F Using Text Mining and Systems Toxicology Approaches
暂无分享,去创建一个
Karine Audouze | Xavier Coumoul | Robert Barouki | Marylène Rugard | Jean-Charles Carvaillo | X. Coumoul | Marylène Rugard | Jean-Charles Carvaillo | R. Barouki | K. Audouze | Karine Audouze
[1] M. Metzler,et al. The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups. , 1998, Environmental health perspectives.
[2] M. Derwahl,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Estrogen Promotes Growth of Human Thyroid Tumor Cells by Different Molecular Mechanisms* , 2022 .
[3] R. Sutherland,et al. Estrogen and Progestin Regulation of Cell Cycle Progression , 2004, Journal of Mammary Gland Biology and Neoplasia.
[4] K. Satoh,et al. Study on anti-androgenic effects of bisphenol a diglycidyl ether (BADGE), bisphenol F diglycidyl ether (BFDGE) and their derivatives using cells stably transfected with human androgen receptor, AR-EcoScreen. , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[5] C. Klinge,et al. Resveratrol and Estradiol Rapidly Activate MAPK Signaling through Estrogen Receptors α and β in Endothelial Cells* , 2005, Journal of Biological Chemistry.
[6] C. Klinge,et al. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. , 2005, The Journal of biological chemistry.
[7] Pall I. Olason,et al. A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.
[8] Nicolas J Cabaton,et al. Genotoxic and endocrine activities of bis(hydroxyphenyl)methane (bisphenol F) and its derivatives in the HepG2 cell line. , 2009, Toxicology.
[9] C. Klinge,et al. Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta. , 2010, International journal of oncology.
[10] David M. Reif,et al. In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project , 2009, Environmental health perspectives.
[11] Daniel L Villeneuve,et al. Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.
[12] Søren Brunak,et al. Deciphering Diseases and Biological Targets for Environmental Chemicals using Toxicogenomics Networks , 2010, PLoS Comput. Biol..
[13] Song-Yu Yang,et al. Hydroxysteroid (17β) dehydrogenase X in human health and disease , 2011, Molecular and Cellular Endocrinology.
[14] K. Audouze,et al. Application of Computational Systems Biology to Explore Environmental Toxicity Hazards , 2011, Environmental health perspectives.
[15] David M. Reif,et al. Update on EPA's ToxCast program: providing high throughput decision support tools for chemical risk management. , 2012, Chemical research in toxicology.
[16] Mariana F. Fernández,et al. In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors. , 2013, Toxicology and applied pharmacology.
[17] M F Wilks,et al. Bisphenol A--Why an adverse outcome pathway framework needs to be applied. , 2014, Toxicology letters.
[18] Sharon Munn,et al. Adverse outcome pathway (AOP) development I: strategies and principles. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.
[19] Andrew Worth,et al. Applying Adverse Outcome Pathways (AOPs) to support Integrated Approaches to Testing and Assessment (IATA). , 2014, Regulatory toxicology and pharmacology : RTP.
[20] F. Santini,et al. Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. , 2014, European journal of endocrinology.
[21] A. Vinggaard,et al. A computational approach to mechanistic and predictive toxicology of pesticides. , 2014, ALTEX.
[22] Soria Eladak,et al. A new chapter in the bisphenol A story: bisphenol S and bisphenol F are not safe alternatives to this compound. , 2015, Fertility and sterility.
[23] Dries Knapen,et al. The potential of AOP networks for reproductive and developmental toxicity assay development. , 2015, Reproductive toxicology.
[24] Natàlia Garcia-Reyero,et al. Are adverse outcome pathways here to stay? , 2015, Environmental science & technology.
[25] Stephen W. Edwards,et al. An integrative data mining approach to identifying adverse outcome pathway signatures. , 2016, Toxicology.
[26] Kazuya Sato,et al. PPARγ antagonist attenuates mouse immune-mediated bone marrow failure by inhibition of T cell function , 2016, Haematologica.
[27] S. Brunak,et al. A scored human protein–protein interaction network to catalyze genomic interpretation , 2017, Nature Methods.
[28] Antony J. Williams,et al. The CompTox Chemistry Dashboard: a community data resource for environmental chemistry , 2017, Journal of Cheminformatics.
[29] Thomas C. Wiegers,et al. Chemical-Induced Phenotypes at CTD Help Inform the Predisease State and Construct Adverse Outcome Pathways , 2018, Toxicological sciences : an official journal of the Society of Toxicology.
[30] Eeva Leinala,et al. Integrated Approaches to Testing and Assessment: OECD Activities on the Development and Use of Adverse Outcome Pathways and Case Studies , 2018, Basic & clinical pharmacology & toxicology.
[31] Georgia Tsiliki,et al. A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions , 2017, Toxicological sciences : an official journal of the Society of Toxicology.
[32] Sharon Munn,et al. Adverse outcome pathway networks I: Development and applications , 2018, Environmental toxicology and chemistry.
[33] K. Audouze,et al. A systems biology approach to predictive developmental neurotoxicity of a larvicide used in the prevention of Zika virus transmission , 2018, Toxicology and applied pharmacology.
[34] Daniel L Villeneuve,et al. Extracting and Benchmarking Emerging Adverse Outcome Pathway Knowledge , 2019, Toxicological sciences : an official journal of the Society of Toxicology.
[35] T. Thalhammer,et al. Future Aspects for Cannabinoids in Breast Cancer Therapy , 2019, International journal of molecular sciences.
[36] K. Ahn,et al. Novel Galiellalactone Analogues Can Target STAT3 Phosphorylation and Cause Apoptosis in Triple-Negative Breast Cancer , 2019, Biomolecules.
[37] Olivier Taboureau,et al. sAOP: linking chemical stressors to adverse outcomes pathway networks , 2019, Bioinform..
[38] Jing Wang,et al. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs , 2019, Nucleic Acids Res..
[39] Minoru Kanehisa,et al. New approach for understanding genome variations in KEGG , 2018, Nucleic Acids Res..
[40] Karine Audouze,et al. Linking Bisphenol S to Adverse Outcome Pathways Using a Combined Text Mining and Systems Biology Approach , 2019, Environmental health perspectives.
[41] Edward J Perkins,et al. Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment , 2019, Environmental toxicology and chemistry.
[42] L. Bláha,et al. Prioritization of hazards of novel flame retardants using the mechanistic toxicology information from ToxCast and Adverse Outcome Pathways , 2019, Environmental Sciences Europe.